Nie, Bilin <br/><br/>
AKAP150 involved in paclitaxel-induced neuropathic pain via inhibiting CN/NFAT2 pathway and downregulating IL-4.  [electronic resource] 

 -  Brain, behavior, and immunity  02 2018 
 - 158-168 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1090-2139 
<br/><br/><label>Standard No.: </label>10.1016/j.bbi.2017.10.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>A Kinase Anchor Proteins--metabolism<br/>Animals<br/>Calcineurin--drug effects<br/>Cytokines--metabolism<br/>Down-Regulation<br/>Ganglia, Spinal--metabolism<br/>Hyperalgesia--metabolism<br/>Injections, Spinal<br/>Interleukin-4--metabolism<br/>Male<br/>NFATC Transcription Factors--drug effects<br/>Neuralgia--metabolism<br/>Paclitaxel--adverse effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Spinal Cord--metabolism<br/>Up-Regulation